Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments Read more
Shire submits lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe Read more
Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development Read more